Early outcomes after transoral CO2 laser resection of laryngeal and hypopharyngeal squamous cell carcinoma: One centre's experience by Leong S.C. et al.
Main Article
Early outcomes after transoral CO2 laser resection of
laryngeal and hypopharyngeal squamous cell carcinoma:
one centre’s experience
S C LEONG, C KATHAN*, S MORTIMORE†
Abstract
Objectives: To review early oncological outcomes following transoral CO2 laser resection of laryngeal and
hypopharyngeal squamous cell carcinoma.
Design: Retrospective review of hospital electronic database.
Setting: Large district general hospital in England, UK.
Main outcome measures: Patients’ three-year disease-specific survival and disease-free survival were
evaluated, including post-operative complications, voice quality and swallowing status.
Results: Seventy-seven patients (16 women and 61 men) were identified. Transoral laser excision of
squamous cell carcinoma of the larynx was undergone by 65 patients, and the same procedure in the
hypopharynx by 12. Patients with laryngeal cancer had statistically better disease-specific survival
than those with hypopharyngeal cancer ( p ¼ 0.021), although the cumulative disease-free survival
probability was 0.71 for both larynx and hypopharynx groups. Patients who underwent laryngectomy
following failed laser treatment or as a salvage procedure had poorer outcomes.
Conclusions: The overall results of this study were comparable with those of other, larger studies. At
three-year follow up, cumulative disease-specific survival probabilities were 0.92 and 0.71 for laryngeal
and hypopharyngeal squamous cell carcinoma, respectively.
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Introduction
Controversy still exists over the optimal treatment for
laryngeal cancer.1 For early lesions (i.e. tumour (T)1
and T1b), treatment options include radiotherapy and
various surgical procedures (e.g. transoral laser micro-
surgery and transcervical partial laryngectomy).2 For
more advanced laryngeal cancer, many treatment
options (and outcomes) have been reported, including
radiotherapy, chemo-radiation, and partial and total
laryngectomy with prosthetic speech rehabilitation.
Recently, some European centres have reported
favourable oncological results after treating more
advanced supraglottic and glottic laryngeal cancer
with laser resection.3,4
The aim of this paper was to review the oncologi-
cal outcomes of patients undergoing transoral CO2
laser resection of laryngeal and hypopharyngeal
squamous cell carcinoma, focusing specifically on




The ENT department at Derby Hospitals National
Health Service Foundation Trust is part of the
regional head and neck cancer network covering
southern Derbyshire and eastern Staffordshire
(England, UK), and serves a population of over
800 000. This region has a mix of rural and urban
populations undertaking industrial, agricultural and
non-manual employment. The ENT department is
based at the Derby Royal Infirmary, a busy district
general hospital. Since August 2001, the senior
author (SM) had kept an electronic database pro-
spectively recording the details for all patients
treated with transoral CO2 laser resection for
mucosal tumours of the upper aerodigestive tract,
within the department.
The current study included patients with histologi-
cally proven squamous cell carcinoma (SCC) of the
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larynx and hypopharynx. Patients lost to follow up or
transferred to other hospitals were excluded, as were
those who had not completed 12 months of follow up.
Methods
The management of all patients was discussed at the
local head and neck multidisciplinary team (MDT)
meeting.
Pre-operative tumour staging was performed by
endoscopy and radiological imaging (i.e. computed
tomography (CT) of the neck and chest). All patients
were staged according to the International Union
Against Cancer – American Joint Commission on
Cancer 2002 staging system.
Transoral laser surgery was performed by the
senior author with a 40 W Sharplan Acublade CO2
laser (Lumenis, London, UK) mounted on a surgical
microscope (Leica, Milton Keynes, UK). It was
the standard practice of the corresponding author
to perform a single resection followed by close
surveillance.
A second procedure was planned if the histology
report suggested involvement of the margins, or if
the corresponding author was concerned about
incomplete clearance. A repeat procedure to resect
the margin and remove granulation tissue was also
planned if the wound did not heal by six weeks
post-operatively.
The post-operative follow-up regime for head and
neck cancer patients in our department was as
follows: monthly in the first year, bimonthly in the
second year, four-monthly in the third and fourth
years, and six-monthly in the fifth year.
Failed laser treatment was defined as the existence
of evidence of residual tumour, due to the inability to
obtain clear margins (surgically or histologically),
and the requirement for another form of treatment
(e.g. total laryngectomy), including palliation.
Residual disease was defined as unclear resection
margins, or evidence of tumour regrowth within 12
months of the first laser resection.
Salvage surgery was undertaken for recurrence
not amenable to further laser resection. In our
series, salvage surgery procedures included total
laryngectomy and neck dissection. Recurrence was
defined as histological evidence of clear margins
after resection, plus subsequent histological evidence
of pathology at least 12 months after the latest laser
resection. Post-operative radiotherapy was given to
the primary site and neck based on clinicopathologi-
cal risk factors, including: positive or close surgical
margins; multiple lymph node involvement in the
neck; extracapsular spread; or histopathological indi-
cators of aggressive disease, such as perineural
invasion, vascular invasion and poor differentiation.
Ethical considerations
Institutional review board approval was not required
for this retrospective review. The encrypted elec-
tronic database was kept on a hospital computer in
a secure location, and was accessed by a password
known only to the first and third authors.
Statistical analysis
Statistical analysis of the data was performed using
the Statistical Package for the Social Sciences
version 11.5 software (SPSS Inc, Chicago, Illinois,
USA). All survival rates were calculated by the
Kaplan–Meier method from the first day of laser
resection. Survival probabilities with 95 per cent con-
fidence interval were estimated, and the log rank
(Cox–Mantel) test was performed for comparison.
Patients’ three-year disease-specific survival and
disease-free survival were evaluated. Results were
regarded as statistically significant if p was less than
0.05. Survival data were calculated using the
Kaplan–Meier method. The study was limited to
reviewing oncological outcomes during the first
three years after laser resection.
Results
Database entries from 1 August 2001 to 31 August
2008 were retrospectively reviewed. Seventy-seven
patients (16 women and 61 men) fulfilling the
inclusion criteria were identified from the database.
The mean age of patients at diagnosis was 65 years
(range 35–93 years).
Of the 77 patients, 65 underwent transoral laser
excision of laryngeal SCC and 12 underwent trans-
oral laser excision of hypopharyngeal SCC. A total
of 161 laser procedures were performed. Each
patient had an average of two laser procedures
throughout the review period. The most frequent
sites of laryngeal involvement were the vocal fold
(31.2 per cent) and anterior commissure (19.9 per
cent). The most frequent site of hypopharyngeal
involvement was the pyriform fossa (63 per cent).
Within the three-year post-operative period assessed
by this study, the mean follow-up period was 24
months (median 27 months, standard deviation
(SD) 11 months).
Tumour staging was upgraded in 26 patients at the
time of first laser resection. The most common
change was from T1b to T2 (occurring in five patients)
and from T3 to T4 (in four patients), followed by T1a
to T2 and T2 to T4 (three cases each). Staging was
downgraded in only one patient, from T4 to T3.
Four patients (three with laryngeal SCC and one
with hypopharyngeal SCC) underwent palliative
laser debulking of the tumour to improve their
airway, in order to avoid a tracheostomy. These
patients had either T3 or T4 laryngeal disease at the
time of presentation. Three subsequently died of
their disease, one due to a second bronchogenic
carcinoma.
One patient (with T4 disease) underwent laser
debulking to improve their airway whilst awaiting
MDT discussion. This patient subsequently under-
went total laryngectomy and bilateral selective neck
dissection, and was alive at last review.
Another patient presented with a suspicious
finding on a chest CT, and underwent laser debulking
of a T4 tumour whilst awaiting bronchial biopsy.
This biopsy was reported as negative; however, by
the time this patient was reassessed by the senior
surgeon, the tumour was deemed too large for
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transoral laser resection. This patient went on to
undergo total laryngectomy and bilateral selective
neck dissection, but died of cardiorespiratory
co-morbidity 13 months post-operatively.
Primary laser resection was abandoned in two
patients (both with T4 laryngeal SCC) due to exten-
sive tumour invasion, in favour of total laryngectomy.
One patient died of metastatic lung cancer, whilst
the other remained disease-free following total
laryngectomy.
In the remaining 69 patients, laser resection was
undertaken with curative intent; the results are
described in detail below. The distribution of laryn-
geal and hypopharyngeal tumours is shown in
Table I. The most common laryngeal tumour stage
was T2 (38 per cent), followed by T3 (22 per cent),
whilst 82 per cent of hypopharyngeal tumours were
either T3 or T4. No patients had detectable metastatic
disease (i.e. they were M0) at the time of first laser
resection. Fifty-eight patients (84 per cent) were
treated for laryngeal and 11 (16 per cent) for hypo-
pharyngeal disease. At the latest clinic consultation,
93 per cent (54/58) and 73 per cent (eight of 11) of
the laryngeal and hypopharyngeal group, respect-
ively, were alive and had no evidence of recurrent
disease.
In the laryngeal group (n ¼ 58), five patients
received radiotherapy as the primary treatment
modality; four of these subsequently underwent
laser resection for recurrence, and one had laser
resection for disease which was unresponsive to
radiotherapy. This latter patient eventually under-
went total laryngectomy for failed laser treatment.
During the review period, a total of 15 patients
suffered recurrent disease following laser resection
(Table II). The average delay from first laser treat-
ment to recurrence was 18.8 months (range 17–116
months). Thirteen of these patients had recurrent
disease at the primary site, whilst two suffered
regional recurrence in the neck. Twelve patients
with recurrent disease at the primary site underwent
repeated laser resection (Table II). However, four of
these patients eventually underwent total laryngect-
omy and neck dissection, two after failed laser treat-
ment and two as salvage treatment. Three of these
laryngectomised patients (one failed and two
salvage) were alive at latest follow up, whilst the
fourth died of stomal recurrence 18 months after
surgery. Of the other eight patients who underwent
repeated laser resection, three also received
chemo-radiotherapy and one radiotherapy. All
eight patients were alive and disease-free at the last
consultation. One patient with recurrence at the
primary site declined any further treatment; this
patient received palliative care, and died during the
review period. The two patients who developed
regional neck recurrence were treated with selective
neck dissection. Both patients were alive at latest
follow up.
The other 43 patients treated for laryngeal SCC
did not suffer recurrence during the review period.
These included two patients who required total lar-
yngectomy and selective neck dissection due to
failed laser treatment at the primary resection but
who had since remained disease-free (Table III).
Five other patients underwent neck dissections
(three bilateral and two unilateral) for node (N)0,
N2a, N2b, N2c and N3 nodal disease, variously. All
but two remained alive during the review period.
The two deaths were not related to the primary laryn-
geal tumour; one patient died of congestive heart
failure following myocardial infarction, whilst the
other died of peritonitis due to a second primary car-
cinoma of the colon. Both cases of failed laser treat-
ment in the laryngeal cohort underwent total
laryngectomy for persistent residual tumour on the
resection margins within 12 months of the first laser
resection (mean 5.3 months, range three to nine
months), and were alive at latest review.
A total of 11 patients ( five women and six men)
were treated for hypopharyngeal SCC, all of whom
had laser resection as the primary treatment
modality. None of these suffered recurrent disease
during the review period (Table III). Nine patients
also underwent neck dissection ( five bilateral and
four ipsilateral). Three deaths were recorded in the
hypopharyngeal group, two due to metastatic
pulmonary involvement and the other due to con-
comitant anaplastic carcinoma of the thyroid. The
surviving eight patients were disease-free at the
latest review, although one patient required laryngo-
pharyngectomy, neck dissection and a gastric pull-up
procedure for a second primary carcinoma of the
cervical oesophagus. All patients in this cohort
required percutaneous gastrostomy feeding, and 10
patients also received post-operative radiotherapy.
No laryngectomies were performed for functional
reasons.
Over a quarter (26 per cent) of patients in the
study cohort required a percutaneous gastrostomy
tube, including all those treated for hypopharyngeal
SCC (Table IV). The percutaneous gastrostomy
was temporary in 17 patients, remaining in place an
average of 31 weeks (range 12–104 weeks, SD 24
weeks). All these patients returned to a normal oral
diet except one, who managed only a liquid diet.
One other patient remained reliant on long-term per-
cutaneous gastrostomy feeding for their nutritional
requirements. A small proportion of patients (4 per
cent) required a temporary nasogastric tube for an
TABLE I
TNM STAGING OF PATIENTS WITH SCC OF LARYNX AND HYPOPHARYNX





T2 22 1 1 1






Data represent patient numbers. All patients had M0
disease. n ¼ 65; †n ¼ 5.
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average of two weeks. Pre-operatively, 76 per cent
of patients managed a normal diet, 11 per cent
required a soft diet and 13 per cent tolerated only
fluids. At one month post-operatively, 69 per cent
of patients had a normal diet, 19 per cent required
a soft diet, 6 per cent managed only fluids and 6
per cent were reliant on percutaneous gastrostomy
feeding. At six months post-operatively, this situ-
ation had improved to 87 per cent on a normal
diet and 10 per cent on a soft diet. The duration of
percutaneous gastrostomy placement was longer
than the delay between laser procedure and com-
mencement of oral intake, as it was usual practice
at our institution to remove the percutaneous gas-
trostomy tube approximately eight weeks after
safe resumption of oral intake.
Of the 62 patients with a preserved larynx, at six-
month follow up, 39 per cent had normal voice
quality, 48 per cent managed telephone conversa-
tions and 16 per cent had only whispered voice.
There were 11 reported post-operative compli-
cations out of 161 laser procedures, giving a compli-
cation rate of 6.8 per cent. No intra-operative or
anaesthetic-related complications were noted. The
most common complication was supraglottic stenosis
( four cases); all of these patients underwent laser
release of the scar tissue, with successful outcomes.
There were three cases of surgical emphysema,
which resolved spontaneously. Two patients had
post-operative bleeding which was managed conser-
vatively, one was treated for pneumonia and one
patient had significant vocal fold adhesion requiring
surgical release. Three patients (two with laryngeal
and one with hypopharyngeal disease) required a
temporary tracheostomy, which was removed an
average of seven days post-operatively. One patient
who was treated for hypopharyngeal SCC (T4 N2C
M0) required a long-term tracheostomy; this patient
remained alive and disease-free five years
post-operatively.
Survival outcomes were analysed for the cohort
treated with curative intent (n ¼ 69). At the latest
clinic review, 93 per cent (54/58) and 73 per cent
(eight of 11) of the laryngeal and hypopharyngeal
group, respectively, were alive and had no evidence
of recurrent disease. Of the 54 laryngeal patients
who were alive, 14 (93 per cent) had T1 tumour, 22
(92 per cent) T2, 15 (100 per cent) T3 and three (75
per cent) T4. In the hypopharyngeal group, three
(60 per cent) patients had T3 tumour, three (75 per
cent) had T4, and one each had T1 and T2
(Table III). The overall average survival period was
32.5 months after primary laser resection. Those
patients with laryngeal cancer had a mean survival
period of 34.3 months, compared with 26.7 months
for patients with hypopharyngeal disease.
TABLE II
OUTCOMES OF PATIENTS PRESENTING WITH RECURRENT LARYNGEAL SCC AFTER PRIMARY LASER RESECTION
Site of recurrence Pts (n) Treatment Outcome (n)
Technique Pts (n) Alive Dead
Primary larynx 13 Repeat laser resection 4 4 0
Repeat laser & post-operative radiotherapy 4 4 0
Palliative† 1 0 1
Total laryngectomy ( for failed laser treatment) 2 1 1
Total laryngectomy ( for salvage procedure) 2 2 0
Neck 2 Selective neck dissection 2 2 0
Total 15 15 13 2
At latest review. †Patient declined further treatment. SCC ¼ squamous cell carcinoma; pts ¼ patients
TABLE III
PATIENT TREATMENT AND OUTCOME BY TUMOUR STAGING AND PRIMARY SITE
















Larynx T1 No 15 0 0 0 0 14 0 1
T2 No 14 0 2 0 1 14 0 0
T2 Yes/local 8 2 2 2 0 6 2 0
T2 Yes/neck 2 0 2 0 1 2 0 0
T3 No 10 0 1 1 0 10 0 0
T3 Yes/local 5 2 1 1 1 5 0 0
T4 No 4 2 4 2 1 3 0 1
Total 58 6 12 6 4 54 2 2
Hypopharynx T1 No 1 0 1 0 1 1 0 0
T2 No 1 0 1 0 1 1 0 0
T3 No 5 0 5 1 4 3 2 0
T4 No 4 1 3 3 0 3 1 0
Total 11 1 10 4 6 8 3 0
At latest review. †Due to squamous cell carcinoma. T ¼ tumour; pts ¼ patients; Lgtmy ¼ laryngectomy; ND ¼ neck dissection;
post-op ¼ post-operative; CRT ¼ chemo-radiotherapy; RT ¼ radiotherapy; DOOD ¼ died of other disease
S C LEONG, C KATHAN, S MORTIMORE188
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0022215109991514
Downloaded from https://www.cambridge.org/core. Bilkent University Library, on 19 Jul 2018 at 15:28:55, subject to the Cambridge Core terms of use, available at
At three-year follow up, the overall disease-
specific survival and disease-free survival probabili-
ties were 0.95 and 0.97, respectively. Patients with
laryngeal cancer had significantly better disease-
specific survival than those with hypopharyngeal
cancer ( p ¼ 0.021, Figure 1), although the disease-
free survival probability three years post-operatively
was 0.71 for both the larynx and hypopharynx groups
(Figure 2, Table V). Differences in disease-free survi-
val between the two groups were not statistically
significant ( p ¼ 0.95). The difference in survival
probabilities was statistically significant ( p ¼ 0.000),
comparing patients undergoing laser resection versus
those who received radiotherapy as the primary treat-
ment modality for laryngeal cancer (Figure 3). Patients
who did not require post-operative radiotherapy
had a slightly better survival outcome than those who
did, but this difference did not reach statistical signifi-
cance (p ¼ 0.59).
Patients who received primary radiotherapy had
poorer outcomes, having a mean survival time of
30.6 months after laser resection for recurrent laryn-
geal disease. Patients who underwent laryngectomy
either for failed laser treatment or as a salvage pro-
cedure also had poorer outcomes, although this
difference did not reach statistical significance ( p ¼
0.30). There was a statistically significant difference
in survival probability ( p ¼ 0.023), comparing
patients with recurrent disease (either at the
primary site or cervical lymphadenopathy) versus
those who remained disease-free after laser resection
(Figure 4). Patients presenting with recurrent cancer
TABLE IV
















Normal Normal Telephone Whispered (n)
Larynx T1 0 0 0 0 0 15 8 7 0
T2 2 0 0 0 0 22 6 12 4
T3 3 2 0 0 3 10 2 7 4
T4 2 0 0 0 1 1 2 0 0
Total 7 2 0 0 4 48 18 26 8
Hypopharynx† T1 1 0 0 0 0 1 1 0 0
T2 1 1 0 0 0 1 1 0 0
T3 5 0 1 0 2 2 2 3 0
T4 4 0 0 1 0 3 2 1 0
Total 11 1 1 1 2 7 6 4 0
n ¼ 58; †n ¼ 11. T ¼ tumour; PEG ¼ percutaneous gastrostomy tube; NGT ¼ nasogastric tube; post-op ¼ used post-operatively;
long-term ¼ used long-term; mths ¼ months; telephone ¼ telephone conversation possible
FIG. 1
Three-year disease-specific survival probability for patients
with laryngeal vs hypopharyngeal squamous cell carcinoma,
p ¼ 0.021. Including censored.
FIG. 2
Three-year disease-free survival probability for patients with
laryngeal vs hypopharyngeal squamous cell carcinoma, p ¼
0.71. Including censored.
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had a significantly poorer outcome, as expected. In
addition, patients presenting with a recurrence in
the larynx had a poorer outcome than those who
had a recurrence in the neck ( p ¼ 0.59) (Figure 5).
Discussion
Squamous cell carcinoma of the upper aerodigestive
tract is the most common cancer of the head and
neck, excluding the skin. External surgery and
chemo-radiotherapy are commonly employed as
standard treatment modalities, whilst the place of
transoral laser excision of glottic cancer is less estab-
lished. Use of this latter treatment modality is highly
dependent on geography, being more popular in
Europe and the US.5,6 Transoral resection of carci-
noma is an emerging procedure in the UK, and is cur-
rently being evaluated in the ‘EaSter’ (Early Stage
glottic cancer: Endoscopic excision or Radiotherapy)
feasibility study.7 Notwithstanding laryngeal preser-
vation, transoral laser surgery is potentially ben-
eficial as it does not preclude further treatments
such as adjuvant radiotherapy, laser retreatment or
salvage surgery. To our knowledge, the current,
single-centre, retrospective study is the first
from the UK to review the oncological outcomes of
CO2 transoral laser resection of upper aerodigestive
tract SCC.
The survival probabilities observed in this study
are comparable to previously published results.
Maurizi et al. reported disease-specific survival and
disease-free survival probabilities of 0.96 and 0.89,
respectively, at three years’ follow up, falling to
0.94 and 0.85 at five years.8 In comparison, the
disease-specific survival and disease-free survival
probabilities observed in the present study were
0.92 and 0.71, respectively, at three years’ follow
up. The differences in outcome were due to the
significantly higher proportion of T1 laryngeal
tumours in Maurizi and colleagues’ study (89 per
cent), compared with our own (only 26 per cent at
presentation). In a multicentre, retrospective review
of 117 patients with advanced glottic carcinoma
treated by laser resection, two- and five-year esti-
mated disease-free survival probabilities were 0.68
and 0.58, respectively.9 The reported two-year
overall survival rate was 75 per cent. Vilaseca et al.
TABLE V
CUMULATIVE PROBABILITIES FOR PATIENTS’ DISEASE-SPECIFIC AND DISEASE-FREE SURVIVAL
Time since first laser (yr) DSS DFS
Larynx Hypopharynx Larynx Hypopharynx
1 1.00 0.91 0.86 0.91
2 0.98 0.71 0.74 0.71
3 0.92 0.71 0.71 0.71
Yr ¼ years; DSS ¼ disease-specific survival; DFS ¼ disease-free survival
FIG. 3
Three-year survival probability for patients undergoing laser
resection vs radiotherapy, as first treatment for laryngeal
squamous cell carcinoma, p ¼ 0.000. Including censored.
FIG. 4
Three-year survival probability for laryngeal squamous cell
carcinoma patients suffering recurrence (primary site or
cervical lymphadenopathy) vs those remaining disease-free,
after laser resection, p ¼ 0.023. Including censored.
S C LEONG, C KATHAN, S MORTIMORE190
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0022215109991514
Downloaded from https://www.cambridge.org/core. Bilkent University Library, on 19 Jul 2018 at 15:28:55, subject to the Cambridge Core terms of use, available at
reported a local recurrence rate of 23 per cent in their
cohort of 28 patients treated for laryngeal SCC, with
a disease-specific survival probability of 0.59 at four-
year follow up.10 The local recurrence rate in the
present study was similar (at 25 per cent), probably
due to the comparable proportions of T2 and T3
tumours in both studies. The overall larynx preser-
vation rate in this study was 90 per cent, which was
comparable to other published results. Eckel et al.
reported an organ preservation rate of 92 per cent
at both two- and five-year follow up, although their
cohort had predominantly lower stage cancers.11
Whilst transoral laser surgery is generally regarded
as safe, it is not without complications, including fatal
consequences. Hinni et al. reported one death due to
aspiration of a blood clot during a planned ‘second
look’ procedure, and three other deaths related to
patients’ medical co-morbidities, within one month
of surgery. In a large series of 275 cases reported
by Vilaseca-González et al., the only complication
observed during laser resection was ignition of the
adhesive strips used to attach two Teflonw injection
catheters, in a patient receiving high frequency
jet ventilation; however, 18.9 per cent of patients
suffered post-operative complications, including
local infection, emphysema, cutaneous fistula,
post-operative bleeding and pneumonia.12 No
treatment-related deaths occurred in this study,
although there was one case of post-operative pneu-
monia attributed to pre-existing poor respiratory
function. In this study, the proportion of patients
reliant on nasogastric tube feeding for nutritional
intake (4 per cent) was lower than reported
elsewhere. In a cohort of 172 hypopharyngeal SCC
cases studied by Martin et al., 80 per cent of patients
required a nasogastric tube for one week (range 1–
110 days).6 The standard practice in our department
was to electively insert a percutaneous gastrostomy
tube in all patients with hypopharyngeal carcinoma,
prior to laser resection. We did not experience any
complications with percutaneous gastrostomy in the
current series, and have found this practice useful
in facilitating feeding during the immediate post-
operative period and during post-operative
radiotherapy.
Negative resection margins are an important prog-
nostic indicator in head and neck cancer. Many
cancer centres utilise intra-operative frozen-section
examination to obtain clear margins. The accuracy
of frozen-section diagnosis is well established, but is
dependent on the experience and technique of the
pathologist and supporting laboratory technicians.13
Frozen-section examination also allows a positive
margin to be corrected before surgical closure and
reconstruction.14 These factors may be important in
external laryngeal surgery but are generally less rel-
evant in transoral resection, as reconstruction of the
aerodigestive tract is not normally required, and
returning to the operating theatre for further laser
resection is less complex than with open procedures
where tissues have been reconstructed. Healing of
exposed areas occurs by secondary intention. Frozen-
section examination for laryngeal cancer is not
without problems. Discrepancies have been reported
by some authors, with up to 5 per cent of frozen-
section samples obtained from laryngeal specimens
being false negative.15,16 False positive reports have
also been noted, resulting in wider resection
margins which complicate surgical closure and sub-
sequent functional outcomes.17
As frozen-section examination was not encour-
aged by our histopathology department, a low
threshold for second look procedures was adopted
in our department as an acceptable practice. All
patients in the current series were made aware of
this possibility during the consent process. Each
patient underwent an average of two laser pro-
cedures throughout the review period (range one to
seven). Some patients who had more procedures sub-
sequently underwent total laryngectomy for failed
laser treatment. The overall rate of failed laser
surgery in this study was 6 per cent ( four of 69),
and all of these patients had their tumour staging
upgraded. The second procedure was frequently
planned based on either positive margins or on clini-
cal suspicion during routine follow up. In some cases,
resection of large tumours was abandoned in favour
of total laryngectomy when it was realised that the
tumour was too extensive for transoral resection. In
a retrospective series of 1467 patients operated
upon by Steiner and Abrosch, patient survival was
similar regardless of whether clear resection
margins were obtained during the first laser pro-
cedure or during revision surgery.18 Kim et al. rec-
ommended that radiological staging of laryngeal
cancers be correlated with endoscopic findings.19 In
their review of CT scans, the rate of false diagnosis
FIG. 5
Three-year survival probability for laryngeal squamous cell
carcinoma patients suffering no recurrence, recurrence in the
neck and recurrence in the larynx. p ¼ 0.59, neck recurrence
vs laryngeal recurrence. Including censored.
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associated with overstaging was 21 per cent, and that
associated with understaging 4 per cent. The current
study observed no adverse events associated with
elective returns to the operating theatre. In fact,
Roh et al. advocated a second look procedure as an
acceptable practice to detect early recurrence and
to manage airway problems.
Unlike external surgery, in which the tumour is
normally excised en bloc ( following Halsted’s prin-
ciple), laser resection allows the surgeon to assess
the tumour by cutting through malignant tissues
without the risk of disseminating disease. This tech-
nique also allows better assessment of the extent of
tumour spread and depth of invasion; this explains
the change in tumour staging of 27 patients in this
series. Accurate grading of laryngeal tumours is
important, considering the potential choice of treat-
ment options and subsequent prognostic impli-
cations. Tumour upgrading is not always possible
with other techniques, such as CT and magnetic
resonance imaging (MRI), other than by histologi-
cal examination of the excised larynx. Possible
discrepancies in tumour staging also makes com-
parison of the oncological outcomes of radiotherapy
and laser resection difficult, as study cohorts may
not have similar tumour stages. Transoral laser
resection has the advantage of allowing the
surgeon to visualise and manipulate the lesion.
The tumour can be transected to enable the
surgeon to estimate its depth of penetration.
Tumour extension is usually clearly distinguishable
under the microscope, and the lesion is resected
until healthy tissue is found and an appropriate
safety margin achieved. This can be seen on the
cut surface under high magnification, and enables
the surgeon to determine a clear surgical margin.
In addition, the initial diagnostic endoscopy pro-
cedure was frequently not performed by the senior
surgeon (SM), and this may have contributed to
the relatively high proportion (35 per cent) of
patients with altered tumour staging. As CO2 laser
vaporises tissue, the heat generated seals the
exposed tissue surface.20 The resultant carbonis-
ation of the tissue edges destroys a few cell layers,
thus preserving the main histological sample.21
The completeness of tumour excision as determined
by the histopathologist should be correlated with
the surgeon’s intra-operative evaluation, aided by
the operating microscope. Surgical experience,
together with feedback from histopathological
reports, helps to develop practical clinical accuracy
in deciding which specific areas to resect.21
In the present study, of those patients with recur-
rent laryngeal disease at the primary site, 62 per
cent (eight of 13) had T2 tumours at presentation,
and T3 tumours were found in the remaining 38 per
cent. All recurrences were confirmed histologically
on the grounds of clinical suspicion during routine
follow up. In order to maximise functional preser-
vation, the senior surgeon was possibly too conserva-
tive in the resection of T2 tumours, being aware that
there is a higher expectation of preserving vocal func-
tion in lower staged tumours. The fact that there were
relatively fewer recurrences in cases with more
advanced tumour may be because the surgeon under-
took a more aggressive resection, as there is a
lowered expectation of preserving vocal function in
more advanced tumours.
The current practice in our department of fre-
quent follow up of all patients in the first two
years after surgery appears to be acceptable.
Patients were not rescanned during the follow-up
period unless this was clinically warranted. In fact,
routine post-operative scanning has not been rec-
ommended by the National Institute for Health
and Clinical Excellence.22 Magnetic resonance
imaging appears to be more specific in detecting
neoplastic cartilage invasion than CT, but tends to
underestimate soft tissue invasion and may there-
fore result in undertreatment.23 The superiority of
MRI lies in its ability to detect intra-cartilaginous
tumour spread. Unfortunately, MRI findings
suggesting neoplastic cartilage invasion may be
false positive, due to small tumour volume and
abnormal MRI signal pattern in cartilage.24 Overes-
timation of the size of the tumour is possible if the
tumour is surrounded by inflammatory changes,
oedema or fibrosis, again causing false positive
reporting. Submucosal tumour spread or cartilagi-
nous invasion can result in an underestimation of
the extent of the lesion (i.e. a false negative). In
addition, problems with movement artefacts fre-
quently occur during imaging of the larynx,
making interpretation more difficult. For instance,
falsely presumed infiltration of the cricoid or
thyroid cartilage (i.e. a false positive finding) on
scanning a carcinoma of the anterior glottis with
subglottic extension may suggest the need for laryn-
gectomy, leading to overtreatment. Missed carti-
lage invasion could lead to ‘undertreatment’ in
the form of radiation alone.
. This study reviewed early oncological
outcomes following transoral CO2 laser
resection of laryngeal and hypopharyngeal
squamous cell carcinoma (SCC)
. Patients with laryngeal SCC had significantly
better disease-specific survival than those with
hypopharyngeal SCC
. Patients who underwent laryngectomy, either
for failed laser treatment or as a salvage
procedure, had poorer outcomes
. Patients’ overall disease-specific survival
probabilities were 0.92 and 0.71 for laryngeal
and hypopharyngeal SCC, respectively, at
three-year follow up; this is comparable to the
results of other, larger studies
Laser resection avoids the need to cut through
tissues that are free of tumour, thereby maximising
the function of the remaining normal tissue.
Therefore, this technique has potential advantages
over external surgery, including the preservation
of voice function and the avoidance of
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potential aspiration, dysphagia and a permanent
stoma.
The present study had a comparatively smaller
cohort of patients compared with previously pub-
lished studies from more established centres.
Nonetheless, we believe the overall results of this
study are comparable to those of other, larger
studies; our patients’ disease-specific survival prob-
abilities were 0.92 and 0.71 for laryngeal and hypo-
pharyngeal SCC, respectively, at three-year follow
up.
Conclusion
We intend to continue offering transoral CO2 laser
resection of laryngeal and hypopharyngeal SCC as
an option to patients, and in time we will evaluate
our long-term outcomes. We believe that the avail-
ability of a selection of treatment modalities (such
as radiotherapy, combination chemo-radiotherapy,
open surgery and transoral laser resection) is advan-
tageous to patients and doctors alike. It is conceiv-
able that, in time, the use of co-morbidity
evaluations and retrospective quality of life assess-
ments will enable clinicians to better determine
which treatment modality is best suited to individual
patients, distinguishing even between those with the
same tumour stage.
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6 Martin A, Jäckel MC, Christiansen H, Mahmoodzada M,
Kron M, Steiner W. Organ preserving transoral laser
microsurgery for cancer of the hypopharynx. Laryngo-
scope 2008;118:398–402
7 Dey P, Arnold D, Wight R, MacKenzie K, Kelly C, Wilson
J. Radiotherapy versus open surgery versus endolaryngeal
surgery (with or without laser) for early laryngeal squa-
mous cell cancer. Cochrane Database Syst Rev 2002;(2):
CD002027
8 Maurizi M, Almadori G, Plaudetti G, De Corso E, Galli J.
Laser carbon dioxide cordectomy versus open surgery in
the treatment of glottic carcinoma: our results. Otolaryngol
Head Neck Surg 2005;132:857–61
9 Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden
RE, Martin A et al. Transoral laser microsurgery for
advanced laryngeal cancer. Arch Otolaryngol Head Neck
Surg 2007;133:1198–204
10 Vilaseca I, Blanch JL, Bernal-Sprekelsen M, Moragas M.
CO2 laser surgery: a larynx preservation alternative for
selected hypopharyngeal carcinomas. Head Neck 2004;26:
953–9
11 Eckel HE, Staar S, Volling P, Sittel C, Damm M, Junge-
huelsing M. Surgical treatment for hypopharynx carci-
noma: feasibility, mortality, and results. Otolaryngol
Head Neck Surg 2001;124:561–9
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